Events
Customizing Care: Advanced Diagnostics and the Future of Personalized Medicine
Wednesday, February 3, 2010*
12:00 – 1:30 pm EST
To access the archived webcast, please click here.
To access the presentation materials, please click here.
Click here to hear audio of the webinar. To save to your computer, right click and select "Save Target As"
This program will explore the evolving policies that impact the development, commercialization, and clinical use of advanced diagnostic testing and how those policies will shape the future of personalized medicine by enabling or inhibiting more customized care. Presenters will offer insights and discuss key considerations on the following topics:
- Impact of comparative effectiveness research
- Future of co-developed and companion diagnostics
- Federal health reform and beyond—opportunities to support personalized medicine
- Reimbursement for diagnostics
- Innovation incentives and barriers
- Managing potential expansion of FDA regulatory oversight
Speakers
Mara G. Aspinall, President and CEO, On-Q-ity, Inc.
Paul H. Keckley, Ph.D., Executive Director, Deloitte Center for Health Solutions
Sheila D. Walcoff, Partner, McDermott Will & Emery LLP
This program is the third complimentary webcast in a three-part series, Personalized Medicine: Thriving in a Rapidly Changing World, conducted by McDermott Will & Emery and Deloitte LLP. To view the archived replay of the past two webcasts in this series, please click here.
For more information, please contact McDermott Events.
*Rescheduled from January 27, 2010. If you pre-registered for this webcast, then you do not need to register again.
CLE credit is pending in California, Illinois, New York and Texas. A Uniform Certificate of Attendance will be made available to participants requesting CLE credit in all other states. Click here for more upcoming events.
